Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

SDZ NKT 343

Name SDZ NKT 343
Supplier R&D Systems
Catalog 2394
Prices $279.00
Sizes 10 mg
Cas Number 180046-99-5
Chemical Name 1-[[(2-Nitrophenyl)amino]carbonyl]-L-prolyl-N-methyl-3-(2-naphthalenyl)-N-(phenylmethyl)-L-alaninamide
Formula C33H33N5O5
Molecular Weight 579.65
Purity >98%
Supplier Page Shop

Product References

Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor - Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor

Walpole CS, Brown MC, James IF, Campbell EA, McIntyre P, Docherty R, Ko S, Hedley L, Ewan S, Buchheit KH, Urban LA. Br J Pharmacol. 1998 May;124(1):83-92.

2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N - - 2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N -

Walpole C, Ko SY, Brown M, Beattie D, Campbell E, Dickenson F, Ewan S, Hughes GA, Lemaire M, Lerpiniere J, Patel S, Urban L. J Med Chem. 1998 Aug 13;41(17):3159-73.

Selective neurokinin-1 receptor antagonists are anti-hyperalgesic in a model of - Selective neurokinin-1 receptor antagonists are anti-hyperalgesic in a model of

Campbell EA, Gentry CT, Patel S, Panesar MS, Walpole CS, Urban L. Neuroscience. 1998 Dec;87(3):527-32.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved